Small intestine cancer medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Small intestine cancer}} | {{Small intestine cancer}} | ||
{{CMG}}{{AE}}{{Qurrat}} {{PSD}} | {{CMG}}{{AE}}{{Qurrat}}, {{PSD}} | ||
==Overview== | ==Overview== | ||
Best treatment for | Best treatment for cure [[small intestine]] cancer is surgical resection with combination of [[chemotherapy]] or [[radiotherapy]]. If tumor is not curable [[Palliative therapy|palliative surgery]] may be done. [[Chemotherapy]] is used to reduce the likelihood of [[metastasis]], shrink tumor size, and slow tumor growth. [[Chemotherapy]] is often applied after [[surgery]] ([[adjuvant]]), before surgery ([[Neoadjuvant chemotherapy|neo-adjuvant]]), or as primary therapy if surgery is not indicated ([[Palliative care|palliative]]). Other therapies include [[Radiation therapy|radiation]] and support therapies. | ||
==Treatment Strategy== | ==Treatment Strategy== | ||
*The treatment of [[small intestine]] cancer is clinically challenging due to its delayed diagnosis. <ref name="pmid29786046">{{cite journal |vauthors=Tang L, Huang LY, Cui J, Wu CR |title=Effect of Double-Balloon Enteroscopy on Diagnosis and Treatment of Small-Bowel Diseases |journal=Chin. Med. J. |volume=131 |issue=11 |pages=1321–1326 |date=June 2018 |pmid=29786046 |pmc=5987504 |doi=10.4103/0366-6999.232802 |url=}}</ref> | *The treatment of [[small intestine]] cancer is clinically challenging due to its delayed diagnosis.<ref name="pmid29786046">{{cite journal |vauthors=Tang L, Huang LY, Cui J, Wu CR |title=Effect of Double-Balloon Enteroscopy on Diagnosis and Treatment of Small-Bowel Diseases |journal=Chin. Med. J. |volume=131 |issue=11 |pages=1321–1326 |date=June 2018 |pmid=29786046 |pmc=5987504 |doi=10.4103/0366-6999.232802 |url=}}</ref> | ||
*Main stay of the treatment is surgery for these tumors. <ref name="pmid20716869">{{cite journal |vauthors=Ogata Y, Yamaguchi K, Sasatomi T, Uchida S, Akagi Y, Shirouzu K |title=[Treatment and outcome in small bowel cancer] |language=Japanese |journal=Gan To Kagaku Ryoho |volume=37 |issue=8 |pages=1454–7 |date=August 2010 |pmid=20716869 |doi= |url=}}</ref>. | *Main stay of the treatment is surgery for these tumors.<ref name="pmid20716869">{{cite journal |vauthors=Ogata Y, Yamaguchi K, Sasatomi T, Uchida S, Akagi Y, Shirouzu K |title=[Treatment and outcome in small bowel cancer] |language=Japanese |journal=Gan To Kagaku Ryoho |volume=37 |issue=8 |pages=1454–7 |date=August 2010 |pmid=20716869 |doi= |url=}}</ref>. | ||
*Patients with [[small intestine]] cancer have | *Patients with [[small intestine]] cancer have several treatment options. | ||
*The selection depends on the the size and location of the tumor, metastasis and comorbidities. | *The selection depends on the the size and location of the [[tumor]], [[metastasis]], and comorbidities. | ||
*The options are: | *The options are: | ||
** Surgery | ** [[Surgery]] | ||
**[[Radiation therapy]] | **[[Radiation therapy]] | ||
**[[Chemotherapy]] | **[[Chemotherapy]] | ||
**Combination of methods and palliative treatment | **Combination of methods and palliative treatment | ||
*The capecitabine and oxaliplatin are found effective in some studies.<ref name="pmid20716869">{{cite journal |vauthors=Ogata Y, Yamaguchi K, Sasatomi T, Uchida S, Akagi Y, Shirouzu K |title=[Treatment and outcome in small bowel cancer] |language=Japanese |journal=Gan To Kagaku Ryoho |volume=37 |issue=8 |pages=1454–7 |date=August 2010 |pmid=20716869 |doi= |url=}}</ref> | *The [[capecitabine]] and [[oxaliplatin]] are found effective in some studies.<ref name="pmid20716869">{{cite journal |vauthors=Ogata Y, Yamaguchi K, Sasatomi T, Uchida S, Akagi Y, Shirouzu K |title=[Treatment and outcome in small bowel cancer] |language=Japanese |journal=Gan To Kagaku Ryoho |volume=37 |issue=8 |pages=1454–7 |date=August 2010 |pmid=20716869 |doi= |url=}}</ref> | ||
*[[Side effect]] | *[[Side effect]] profile varies with each individual as well as each treatment session. | ||
==References== | ==References== | ||
Revision as of 15:34, 16 January 2019
|
Small intestine cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Small intestine cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Small intestine cancer medical therapy |
|
Risk calculators and risk factors for Small intestine cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Parminder Dhingra, M.D. [3]
Overview
Best treatment for cure small intestine cancer is surgical resection with combination of chemotherapy or radiotherapy. If tumor is not curable palliative surgery may be done. Chemotherapy is used to reduce the likelihood of metastasis, shrink tumor size, and slow tumor growth. Chemotherapy is often applied after surgery (adjuvant), before surgery (neo-adjuvant), or as primary therapy if surgery is not indicated (palliative). Other therapies include radiation and support therapies.
Treatment Strategy
- The treatment of small intestine cancer is clinically challenging due to its delayed diagnosis.[1]
- Main stay of the treatment is surgery for these tumors.[2].
- Patients with small intestine cancer have several treatment options.
- The selection depends on the the size and location of the tumor, metastasis, and comorbidities.
- The options are:
- Surgery
- Radiation therapy
- Chemotherapy
- Combination of methods and palliative treatment
- The capecitabine and oxaliplatin are found effective in some studies.[2]
- Side effect profile varies with each individual as well as each treatment session.
References
- ↑ Tang L, Huang LY, Cui J, Wu CR (June 2018). "Effect of Double-Balloon Enteroscopy on Diagnosis and Treatment of Small-Bowel Diseases". Chin. Med. J. 131 (11): 1321–1326. doi:10.4103/0366-6999.232802. PMC 5987504. PMID 29786046.
- ↑ 2.0 2.1 Ogata Y, Yamaguchi K, Sasatomi T, Uchida S, Akagi Y, Shirouzu K (August 2010). "[Treatment and outcome in small bowel cancer]". Gan To Kagaku Ryoho (in Japanese). 37 (8): 1454–7. PMID 20716869.